Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.
FUSID
Prospective Assessment of the Prevalence and Natural History of Gastroesophageal Reflux and Functional Gastro-intestinal Disorders Among At-risk Infants
1 other identifier
observational
71
1 country
1
Brief Summary
The goal of this observational study is to learn about the prevalence and characteristics of functional gastrointestinal disorders (FGID) in at risk infants (former preterm infants and those with birth asphyxia) during the first 2 years of life. The main questions it aims to answer are:
- evaluate the prevalence of symptoms related to gastro-esophageal reflux (GER), of functional gastrointestinal disorders during the first 2 years of life
- describe growth parameters during follow-up up to the corrected age of 2 years Participants will be assessed clinically and with a structured questionnaire based on the Rome IV criteria to describe FGID.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 20, 2022
CompletedFirst Submitted
Initial submission to the registry
August 28, 2023
CompletedFirst Posted
Study publicly available on registry
September 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedMarch 11, 2025
March 1, 2025
3.4 years
August 28, 2023
March 10, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Prevalence of FGID
Occurrence of FGID (percentage of patients)
3, 6, 12, 24 months of corrected age
Frequency of FGID
Frequency of FGID (i.e. number of symptoms per day)
3, 6, 12, 24 months of corrected age
Severity of FGID
Severity (scales from 0 to 10 for increasing values) of FGID
3, 6, 12, 24 months of corrected age
Secondary Outcomes (3)
Somatic growth: weight
3, 6, 12, 24 months of corrected age
Somatic growth: head circumference
3, 6, 12, 24 months of corrected age
Somatic growth: length
3, 6, 12, 24 months of corrected age
Interventions
At each follow up visit, a clinical examination and anthropometric evaluation will be performed. Parents will fill a structured questionnaire to describe the occurrence and characteristics of functional gastrointestinal disorders.
Eligibility Criteria
Infants matching the inclusion criteria will be enrolled in the local Follow-up program (as per clinical routine of the local Institution).
You may qualify if:
- infants with gestational age at birth \< 31 weeks
- infants with gestational age at birth \< 37 weeks and major respiratory or neurologic morbidity
- infants with history of perinatal asphyxia
You may not qualify if:
- lack of informed consent
- diagnosis of congenital or other major gastrointestinal disease (i.e. inflammatory bowel disease, cancer)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Gemelli IRCCS
Roma, 00168, Italy
Related Publications (5)
Steutel NF, Zeevenhooven J, Scarpato E, Vandenplas Y, Tabbers MM, Staiano A, Benninga MA. Prevalence of Functional Gastrointestinal Disorders in European Infants and Toddlers. J Pediatr. 2020 Jun;221:107-114. doi: 10.1016/j.jpeds.2020.02.076.
PMID: 32446468RESULTRobin SG, Keller C, Zwiener R, Hyman PE, Nurko S, Saps M, Di Lorenzo C, Shulman RJ, Hyams JS, Palsson O, van Tilburg MAL. Prevalence of Pediatric Functional Gastrointestinal Disorders Utilizing the Rome IV Criteria. J Pediatr. 2018 Apr;195:134-139. doi: 10.1016/j.jpeds.2017.12.012. Epub 2018 Feb 3.
PMID: 29398057RESULTBenninga MA, Faure C, Hyman PE, St James Roberts I, Schechter NL, Nurko S. Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterology. 2016 Feb 15:S0016-5085(16)00182-7. doi: 10.1053/j.gastro.2016.02.016. Online ahead of print.
PMID: 27144631RESULTIacono G, Merolla R, D'Amico D, Bonci E, Cavataio F, Di Prima L, Scalici C, Indinnimeo L, Averna MR, Carroccio A; Paediatric Study Group on Gastrointestinal Symptoms in Infancy. Gastrointestinal symptoms in infancy: a population-based prospective study. Dig Liver Dis. 2005 Jun;37(6):432-8. doi: 10.1016/j.dld.2005.01.009. Epub 2005 Mar 2.
PMID: 15893282RESULTScarpato E, Salvatore S, Romano C, Bruzzese D, Ferrara D, Inferrera R, Zeevenhooven J, Steutel NF, Benninga MA, Staiano A. Prevalence and Risk Factors of Functional Gastrointestinal Disorders: A Cross-Sectional Study in Italian Infants and Young Children. J Pediatr Gastroenterol Nutr. 2023 Feb 1;76(2):e27-e35. doi: 10.1097/MPG.0000000000003653. Epub 2022 Nov 1.
PMID: 36705695RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefano Nobile, MD, PhD, MSc
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 28, 2023
First Posted
September 11, 2023
Study Start
May 20, 2022
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
March 11, 2025
Record last verified: 2025-03